Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway

Proc Natl Acad Sci U S A. 1995 Nov 7;92(23):10599-603. doi: 10.1073/pnas.92.23.10599.

Abstract

The nuclear translocation of NF-kappa B follows the degradation of its inhibitor, I kappa B alpha, an event coupled with stimulation-dependent inhibitor phosphorylation. Prevention of the stimulation-dependent phosphorylation of I kappa B alpha, either by treating cells with various reagents or by mutagenesis of certain putative I kappa B alpha phosphorylation sites, abolishes the inducible degradation of I kappa B alpha. Yet, the mechanism coupling the stimulation-induced phosphorylation with the degradation has not been resolved. Recent reports suggest a role for the proteasome in I kappa B alpha degradation, but the mode of substrate recognition and the involvement of ubiquitin conjugation as a targeting signal have not been addressed. We show that of the two forms of I kappa B alpha recovered from stimulated cells in a complex with RelA and p50, only the newly phosphorylated form, pI kappa B alpha, is a substrate for an in vitro reconstituted ubiquitin-proteasome system. Proteolysis requires ATP, ubiquitin, a specific ubiquitin-conjugating enzyme, and other ubiquitin-proteasome components. In vivo, inducible I kappa B alpha degradation requires a functional ubiquitin-activating enzyme and is associated with the appearance of high molecular weight adducts of I kappa B alpha. Ubiquitin-mediated protein degradation may, therefore, constitute an integral step of a signal transduction process.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / metabolism
  • Amino Acid Sequence
  • Cells, Cultured
  • Cysteine Endopeptidases / drug effects
  • Cysteine Endopeptidases / metabolism*
  • Cysteine Proteinase Inhibitors / pharmacology
  • DNA-Binding Proteins / metabolism*
  • Enzyme Activation
  • Humans
  • I-kappa B Proteins*
  • Ligases / metabolism
  • Molecular Sequence Data
  • Multienzyme Complexes / drug effects
  • Multienzyme Complexes / metabolism*
  • NF-KappaB Inhibitor alpha
  • NF-kappa B / antagonists & inhibitors*
  • Phosphorylation
  • Proteasome Endopeptidase Complex
  • Ubiquitin-Activating Enzymes
  • Ubiquitin-Protein Ligases
  • Ubiquitins / metabolism*

Substances

  • Cysteine Proteinase Inhibitors
  • DNA-Binding Proteins
  • I-kappa B Proteins
  • Multienzyme Complexes
  • NF-kappa B
  • NFKBIA protein, human
  • Ubiquitins
  • NF-KappaB Inhibitor alpha
  • Adenosine Triphosphate
  • Ubiquitin-Protein Ligases
  • Cysteine Endopeptidases
  • Proteasome Endopeptidase Complex
  • Ligases
  • Ubiquitin-Activating Enzymes